John Dorer is CEO of New York City-based EB3.work, a staffing consultancy that helps employers fill positions when they can’t hire locally. Opinions are the author’s own. The labor shortage in the ...

The South Florida Water Management District held a python hunt in December with cash prizes. Kevin Pavlidis won multiple awards, including for most pythons captured and the longest python. The ...

Pearl TV has announced the launch of a converter box program aimed at making NextGen TV, the ATSC 3.0 broadcast standard, accessible to consumers without the need to purchase new television sets. Anne ...

3 Kartoffeln und 3 Eier – und ein köstliches Abendessenrezept ist in 10 Min! Schnelles einfaches Rezept!Rezept und Zutaten: 3 Kartoffeln. Kaltes Wasser. Die Kartoffeln nur 3 Minuten in kaltem Wasser ...

The Navy is walking away from the Constellation-class frigate program to focus on new classes of warships the service can build faster, Secretary of the Navy John Phelan announced Tuesday on social ...

First patient randomized into HELIOS-3, which along with HELIOS-2 form the basis of AXPAXLI’s registrational program in non-proliferative diabetic retinopathy (NPDR) HELIOS-2 and HELIOS-3 are global, ...

The NCAA has announced that after conducting research on a major college football program, that university will be punished in a big way. On Wednesday, the NCAA put the Michigan State football program ...

Solar power has definitively taken over in Australia, the sunniest continent on Earth, to such an extent that the government is proposing a new program offering at least three hours of free ...

G36maid mentioned this in 2 issues on Jan 26 Extension fails to initialize on Python 3.14 (onnxruntime compatibility) G36maid/zed-mcp-server-markitdown#2 Python 3.14 support: Dependency conflict with ...

NOTE: This article was published yesterday (30/10/2025), but due to some technical issues it went offline. Microsoft has officially added Python 3.14 to Azure App Service for Linux. Developers can now ...

Moderna is halting development of an mRNA vaccine for congenital cytomegalovirus after its candidate failed to protect women from the virus in a large phase 3 trial, the biotech announced in a ...